Koji Izutsu
AuthID: R-00H-XEA
1
TÃTULO: Six-Year Results from the Phase 3 Randomized Study Relevance Show Similar Outcomes for Previously Untreated Follicular Lymphoma Patients Receiving Lenalidomide Plus Rituximab (R (2)) Versus Rituximab-Chemotherapy Followed By Rituximab Maintenance
AUTORES: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
AUTORES: Morschhauser, Franck; Nastoupil, Loretta; Feugier, Pierre; De Colella, Jean Marc Schiano; Tilly, Herve; Palomba, M. Lia; Bachy, Emmanuel; Fruchart, Christophe; Libby, Edward; Casasnovas, Rene Olivier; Flinn, Ian W.; Haioun, Corinne; Maisonneuve, Herve; Ysebaert, Loic; Bartlett, Nancy L.; Bouabdallah, Kamal; Brice, Pauline; Ribrag, Vincent; Le Gouill, Steven; Daguindau, Nicolas; ...Mais
PUBLICAÇÃO: 2021, FONTE: BLOOD, VOLUME: 138
INDEXADO EM: 
WOS
WOS2
TÃTULO: Efficacy and time to next treatment following lenalidomide/rituximab (R-2) or rituximab/placebo in patients with R/R indolent NHL (AUGMENT).
AUTORES: John G Gribben; Koji Izutsu; Nathan Hale Fowler; Xiaonan N Hong; Huilai L Zhang; Fritz Offner; Adriana A S Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian Flinn; Claudia Moreira; Stacey Anastasia Kalambakas; Pierre Fustier; Chengqing (Alan) Wu; John Paul Leonard;
PUBLICAÇÃO: 2019, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, NÚMERO: 15
AUTORES: John G Gribben; Koji Izutsu; Nathan Hale Fowler; Xiaonan N Hong; Huilai L Zhang; Fritz Offner; Adriana A S Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian Flinn; Claudia Moreira; Stacey Anastasia Kalambakas; Pierre Fustier; Chengqing (Alan) Wu; John Paul Leonard;
PUBLICAÇÃO: 2019, FONTE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 37, NÚMERO: 15
INDEXADO EM: WOS
WOS3
TÃTULO: AUGMENT: A Phase III Randomized Study of Lenalidomide Plus Rituximab (R-2) Vs Rituximab/Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
AUTORES: John P Leonard; Marek Trneny; Koji Izutsu; Nathan H Fowler; Xiaonan N Hong; Jun Zhu; Huilai L Zhang; Fritz Offner; Adriana Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian W Flinn; Claudia Moreira; David Liu; Stacey Kalambakas; Pierre Fustier; Chengqing Q Wu; ...Mais
PUBLICAÇÃO: 2018, FONTE: 60th Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 132
AUTORES: John P Leonard; Marek Trneny; Koji Izutsu; Nathan H Fowler; Xiaonan N Hong; Jun Zhu; Huilai L Zhang; Fritz Offner; Adriana Scheliga; Grzegorz S Nowakowski; Antonio Pinto; Francesca Re; Laura Maria Fogliatto; Phillip Scheinberg; Ian W Flinn; Claudia Moreira; David Liu; Stacey Kalambakas; Pierre Fustier; Chengqing Q Wu; ...Mais
PUBLICAÇÃO: 2018, FONTE: 60th Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 132
INDEXADO EM: WOS
WOS